MONDELLO, Patrizia
MONDELLO, Patrizia
Dipartimento di Medicina Clinica e Sperimentale
90 Y-ibritumomab tiuxetan: A nearly forgotten opportunity
2016-01-01 Mondello, Patrizia; Cuzzocrea, Salvatore; Navarra, Michele; Mian, Michael
90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST
2014-01-01 Mondello, Patrizia; Altavilla, Giuseppe; Derenzini, E.; Pitini, Vincenzo; Mian, M.
90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment.
2014-01-01 Mondello, Patrizia; Pitini, Vincenzo; Arrigo, C.; Derenzini, E.; Mian, M.
90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?
2016-01-01 Mondello, Patrizia; Steiner, Normann; Willenbacher, Wolfgang; Arrigo, Carmela; Cuzzocrea, Salvatore; Pitini, Vincenzo; Mian, Michael
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma.
2014-01-01 Mian, M; Marcheselli, L; Rossi, A; Visco, C; Chiappella, A; Volpetti, S; Zaja, F; Mondello, Patrizia; Fiegl, M; Billio, A; Federico, M; Luminari, S; Rambaldi, A; Cortelazzo, S.
A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies
2018-01-01 Casey, E; Bournazos, S; Mo, G; Mondello, P; Tan, K S; Ravetch, J V; Scheinberg, D A
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study
2020-01-01 Mondello, Patrizia; Musolino, Caterina; Dogliotti, Irene; Bohn, Jan-Paul; Cavallo, Federica; Ferrero, Simone; Botto, Barbara; Cerchione, Claudio; Nappi, Davide; De Lorenzo, Sonya; Martinelli, Giovanni; Wolf, Dominik; Schmitt, Clemens; Loseto, Giacomo; Cuzzocrea, Salvatore; Willenbacher, Wolfgang; Mian, Michael; Straus, David J
An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules.
2016-01-01 Dao, T.; Korontsvit, T.; Zakhaleva, V.; Jarvis, C.; Mondello, P.; Oh, C.; Scheinberg, D. A.
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation
2015-01-01 Lacquaniti, Antonio; Altavilla, Giuseppe; Picone, Antonio; Donato, Valentina; Chirico, Valeria; Mondello, Patrizia; Aloisi, Carmela; Marabello, Grazia; Loddo, Saverio; Buemi, Antoine; Lorenzano, Giuseppina; Buemi, Michele
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS
2015-01-01 Autore, F.; Innocenti, I.; D'Arena, G.; Coscia, M.; Mondello, Patrizia; Pasquale, R.; Sica, S.; Laurenti, L.
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience
2016-01-01 Laurenti, L.; Autore, F.; Innocenti, I.; D'Arena, G.; Coscia, M.; Mondello, P.; Chiusolo, P.; Bellesi, S.; Efremov, D. G.; Sica, S.; Mauro, F. R.
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
2015-01-01 Laurenti, Luca; Innocenti, Idanna; Autore, Francesco; Vannata, Barbara; Efremov, Dimitar G; Ciolli, Stefania; Del Poeta, Giovanni; Mauro, Francesca Romana; Cortelezzi, Agostino; Borza, Paola Anticoli; Ghio, Francesco; Mondello, Patrizia; Murru, Roberta; Gozzetti, Alessandro; Cariccio, Maria Rosa Lanza; Piccirillo, Nicola; Boncompagni, Riccardo; Cantonetti, Maria; Principe, Maria Ilaria Del; Reda, Gianluigi; Bongarzoni, Velia; Cervetti, Giulia; Pitini, Vincenzo; Foà, Robin; Sica, Simona; D'Arena, Giovanni
Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study
2018-01-01 Mondello, P; Steiner, N; Willenbacher, W; Cerchione, C; Nappi, D; Mauro, E; Ferrero, S; Cuzzocrea, S; Mian, M.
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study
2016-01-01 Mondello, Patrizia; Steiner, Normann; Willenbacher, Wolfgang; Wasle, Ines; Zaja, Francesco; Zambello, Renato; Visentin, Andrea; Mauro, Endri; Ferrero, Simone; Ghione, Paola; Pitini, Vincenzo; Cuzzocrea, Salvatore; Mian, Michael
Bendamustine with Rituximab Is Safe and Effective As FRONT LINE Therapy in Elderly B-CLL Patients. an ITALIAN RETROSPECTIVE MULTICENTER Experience
2014-01-01 Laurenti, L.; Autore, F.; Innocenti, I.; Vannata, B.; Cantonetti, M.; Del Principe, M. I.; Mauro, F. R.; Paola, A. B.; Bongarzoni, V.; Ciolli, S.; Boncompagni, R.; Sciume, M.; Vincenti, D.; Ghio, F.; Cecconi, N.; Pitini, Vincenzo; Mondello, Patrizia; Cariccio, M. R. L.; Gozzetti, A.; D'Arena, G.; Murru, R.; Piccirillo, N.; Petrini, M.; Cortelezzi, A.; Del Poeta, G.; Foa, R.; Sica, S.
BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors
2018-01-01 Derenzini, Enrico; Mondello, Patrizia; Erazo, Tatiana; Portelinha, Ana; Liu, Yuxuan; Scallion, Mary; Asgari, Zahra; Philip, John; Hilden, Patrick; Valli, Debora; Rossi, Alessandra; Djaballah, Hakim; Ouerfelli, Ouathek; de Stanchina, Elisa; Seshan, Venkatraman E.; Hendrickson, Ronald C.; Younes, Anas
Biosimilar epoetin α is as effective as originator epoetin-α plus liposomal iron (Sideral®), vitamin B12 and folates in patients with refractory anemia: A retrospective real-life approach
2015-01-01 Giordano, Giulio; Mondello, Patrizia; Tambaro, Rosa; Perrotta, Nicola; D'Amico, Fabio; D'Aveta, Antonietta; Berardi, Giuseppe; Carabellese, Bruno; Patriarca, Andrea; MARIA CORBI, Grazia; DI MARZIO, Luigi; Licianci, Antonietta; Berardi, Donata; DI LULLO, Liberato; DI MARCO, Roberto
Biosimilar Erythropoietin Alpha Is Effective As Originator Erythropoietin Alpha Plus Liposomial Iron and B12 and Folates in Patients with Refractory Anemia: A Retrospective Real-Life Approach
2014-01-01 Giordano, G; Mondello, Patrizia; Tambaro, R; Perrotta, N; D'Amico, F; Berardi, G.; Carabellese, B; Equitani, F.
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.
2017-01-01 Mondello, Patrizia; Cuzzocrea, Salvatore; Navarra, Michele; Mian, M.
Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?
2016-01-01 Mian, Michael; Tinelli, Martina; DE March, Elena; Turri, Gloria; Meneghini, Vittorio; Pescosta, Norbert; Berno, Tamara; Marabese, Alessandra; Mondello, Patrizia; Patriarca, Francesca; Pizzolo, Giovanni; Semenzato, Gianpietro; Cortelazzo, Sergio; Zambello, Renato
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 90 Y-ibritumomab tiuxetan: A nearly forgotten opportunity | 1-gen-2016 | Mondello, Patrizia; Cuzzocrea, Salvatore; Navarra, Michele; Mian, Michael | |
| 90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST | 1-gen-2014 | Mondello, Patrizia; Altavilla, Giuseppe; Derenzini, E.; Pitini, Vincenzo; Mian, M. | |
| 90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment. | 1-gen-2014 | Mondello, Patrizia; Pitini, Vincenzo; Arrigo, C.; Derenzini, E.; Mian, M. | |
| 90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward? | 1-gen-2016 | Mondello, Patrizia; Steiner, Normann; Willenbacher, Wolfgang; Arrigo, Carmela; Cuzzocrea, Salvatore; Pitini, Vincenzo; Mian, Michael | |
| A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma. | 1-gen-2014 | Mian, M; Marcheselli, L; Rossi, A; Visco, C; Chiappella, A; Volpetti, S; Zaja, F; Mondello, Patrizia; Fiegl, M; Billio, A; Federico, M; Luminari, S; Rambaldi, A; Cortelazzo, S. | |
| A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies | 1-gen-2018 | Casey, E; Bournazos, S; Mo, G; Mondello, P; Tan, K S; Ravetch, J V; Scheinberg, D A | |
| ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study | 1-gen-2020 | Mondello, Patrizia; Musolino, Caterina; Dogliotti, Irene; Bohn, Jan-Paul; Cavallo, Federica; Ferrero, Simone; Botto, Barbara; Cerchione, Claudio; Nappi, Davide; De Lorenzo, Sonya; Martinelli, Giovanni; Wolf, Dominik; Schmitt, Clemens; Loseto, Giacomo; Cuzzocrea, Salvatore; Willenbacher, Wolfgang; Mian, Michael; Straus, David J | |
| An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules. | 1-gen-2016 | Dao, T.; Korontsvit, T.; Zakhaleva, V.; Jarvis, C.; Mondello, P.; Oh, C.; Scheinberg, D. A. | |
| Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation | 1-gen-2015 | Lacquaniti, Antonio; Altavilla, Giuseppe; Picone, Antonio; Donato, Valentina; Chirico, Valeria; Mondello, Patrizia; Aloisi, Carmela; Marabello, Grazia; Loddo, Saverio; Buemi, Antoine; Lorenzano, Giuseppina; Buemi, Michele | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS | 1-gen-2015 | Autore, F.; Innocenti, I.; D'Arena, G.; Coscia, M.; Mondello, Patrizia; Pasquale, R.; Sica, S.; Laurenti, L. | |
| Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience | 1-gen-2016 | Laurenti, L.; Autore, F.; Innocenti, I.; D'Arena, G.; Coscia, M.; Mondello, P.; Chiusolo, P.; Bellesi, S.; Efremov, D. G.; Sica, S.; Mauro, F. R. | |
| Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments | 1-gen-2015 | Laurenti, Luca; Innocenti, Idanna; Autore, Francesco; Vannata, Barbara; Efremov, Dimitar G; Ciolli, Stefania; Del Poeta, Giovanni; Mauro, Francesca Romana; Cortelezzi, Agostino; Borza, Paola Anticoli; Ghio, Francesco; Mondello, Patrizia; Murru, Roberta; Gozzetti, Alessandro; Cariccio, Maria Rosa Lanza; Piccirillo, Nicola; Boncompagni, Riccardo; Cantonetti, Maria; Principe, Maria Ilaria Del; Reda, Gianluigi; Bongarzoni, Velia; Cervetti, Giulia; Pitini, Vincenzo; Foà, Robin; Sica, Simona; D'Arena, Giovanni | |
| Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study | 1-gen-2018 | Mondello, P; Steiner, N; Willenbacher, W; Cerchione, C; Nappi, D; Mauro, E; Ferrero, S; Cuzzocrea, S; Mian, M. | |
| Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study | 1-gen-2016 | Mondello, Patrizia; Steiner, Normann; Willenbacher, Wolfgang; Wasle, Ines; Zaja, Francesco; Zambello, Renato; Visentin, Andrea; Mauro, Endri; Ferrero, Simone; Ghione, Paola; Pitini, Vincenzo; Cuzzocrea, Salvatore; Mian, Michael | |
| Bendamustine with Rituximab Is Safe and Effective As FRONT LINE Therapy in Elderly B-CLL Patients. an ITALIAN RETROSPECTIVE MULTICENTER Experience | 1-gen-2014 | Laurenti, L.; Autore, F.; Innocenti, I.; Vannata, B.; Cantonetti, M.; Del Principe, M. I.; Mauro, F. R.; Paola, A. B.; Bongarzoni, V.; Ciolli, S.; Boncompagni, R.; Sciume, M.; Vincenti, D.; Ghio, F.; Cecconi, N.; Pitini, Vincenzo; Mondello, Patrizia; Cariccio, M. R. L.; Gozzetti, A.; D'Arena, G.; Murru, R.; Piccirillo, N.; Petrini, M.; Cortelezzi, A.; Del Poeta, G.; Foa, R.; Sica, S. | |
| BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors | 1-gen-2018 | Derenzini, Enrico; Mondello, Patrizia; Erazo, Tatiana; Portelinha, Ana; Liu, Yuxuan; Scallion, Mary; Asgari, Zahra; Philip, John; Hilden, Patrick; Valli, Debora; Rossi, Alessandra; Djaballah, Hakim; Ouerfelli, Ouathek; de Stanchina, Elisa; Seshan, Venkatraman E.; Hendrickson, Ronald C.; Younes, Anas | |
| Biosimilar epoetin α is as effective as originator epoetin-α plus liposomal iron (Sideral®), vitamin B12 and folates in patients with refractory anemia: A retrospective real-life approach | 1-gen-2015 | Giordano, Giulio; Mondello, Patrizia; Tambaro, Rosa; Perrotta, Nicola; D'Amico, Fabio; D'Aveta, Antonietta; Berardi, Giuseppe; Carabellese, Bruno; Patriarca, Andrea; MARIA CORBI, Grazia; DI MARZIO, Luigi; Licianci, Antonietta; Berardi, Donata; DI LULLO, Liberato; DI MARCO, Roberto | |
| Biosimilar Erythropoietin Alpha Is Effective As Originator Erythropoietin Alpha Plus Liposomial Iron and B12 and Folates in Patients with Refractory Anemia: A Retrospective Real-Life Approach | 1-gen-2014 | Giordano, G; Mondello, Patrizia; Tambaro, R; Perrotta, N; D'Amico, F; Berardi, G.; Carabellese, B; Equitani, F. | |
| Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression. | 1-gen-2017 | Mondello, Patrizia; Cuzzocrea, Salvatore; Navarra, Michele; Mian, M. | |
| Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma? | 1-gen-2016 | Mian, Michael; Tinelli, Martina; DE March, Elena; Turri, Gloria; Meneghini, Vittorio; Pescosta, Norbert; Berno, Tamara; Marabese, Alessandra; Mondello, Patrizia; Patriarca, Francesca; Pizzolo, Giovanni; Semenzato, Gianpietro; Cortelazzo, Sergio; Zambello, Renato |